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Background
To examine the structural organisation of heterodimeric
soluble guanylyl cyclase (sGC) fluorescence resonance
energy transfer (FRET) was used to estimate distances
between fluorescent proteins fused to the amino- and car-
boxy-terminal ends of the sGC β1 and α subunits.
Methods
The FRET donor, CFP, and FRET acceptor, YFP, were fused
to amino- and carboxy-terminal ends of sGC subunits.
After generation of recombinant baculovirus strains fluo-
rescent tagged sGC subunits were co-expressed in Sf9-
cells. Fluorescent variants of sGC were analyzed in vitro in
cytosolic fractions by sensitized emission FRET. In addi-
tion, fluorescent tagged sGC subunits were analyzed in
vivo using confocal laser scanning microscopy and fluores-
cence lifetime imaging (FLIM) on an inverted microscope.
Results
Carboxy-terminal fluorescent-tagged sGC combinations
displayed NO stimulated sGC activity similar to the non-
tagged sGC heterodimer and showed in vitro and in vivo
FRET values significantly higher than the negative control.
Co-expression of amino-terminally tagged sGC showed
also FRET. However, the enzyme complexes showed only
basal enzyme activity. Co-expression of carboxy-termi-
nally tagged α subunit with amino-terminally tagged β1
subunit yielded a basally active enzyme complex that
showed FRET. Co-expression of the amino-terminally
tagged α subunit with the carboxy-terminally tagged β1
subunit resulted an enzyme complex that showed NO
stimulated activity and FRET.
Discussion
Based on the ability of an amino-terminal construct of the
β1 subunit (HNOX) to inhibit activity of an heterodimer
consisting only of the catalytic domains (αcatβcat), Winger
and Marletta [1] have proposed a direct interaction of the
amino-terminal region of β1 with the catalytic domains.
Our results provide direct evidence that all four subunit
termini of the heterodimeric enzyme complex are in prox-
imity to each other. This supports the concept that sGC is
structurally organized in a way that allows for direct inter-
action of the amino-terminal (HNOX) domains of β1
(and α) with the carboxy-terminal catalytic region.
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